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ARTICLE
Structural Basis of GLUT1 Inhibition by Cytoplasmic ATP
David M. Blodgett, Julie K. De Zutter, Kara B. Levine, Pusha Karim, and Anthony Carruthers
Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605
Cytoplasmic ATP inhibits human erythrocyte glucose transport protein (GLUT1)–mediated glucose transport in 
human red blood cells by reducing net glucose transport but not exchange glucose transport (Cloherty, E.K., 
D.L. Diamond, K.S. Heard, and A. Carruthers. 1996. Biochemistry. 35:13231–13239). We investigated the mecha-
nism of ATP regulation of GLUT1 by identifying GLUT1 domains that undergo signifi  cant conformational 
change upon GLUT1–ATP interaction. ATP (but not GTP) protects GLUT1 against tryptic digestion. Immuno-
blot analysis indicates that ATP protection extends across multiple GLUT1 domains. Peptide-directed antibody 
binding to full-length GLUT1 is reduced by ATP at two specifi  c locations: exofacial loop 7–8 and the cytoplasmic 
C terminus. C-terminal antibody binding to wild-type GLUT1 expressed in HEK cells is inhibited by ATP but 
binding of the same antibody to a GLUT1–GLUT4 chimera in which loop 6–7 of GLUT1 is substituted with loop 
6–7 of GLUT4 is unaffected. ATP reduces GLUT1 lysine covalent modifi  cation by sulfo-NHS-LC-biotin by 40%. 
AMP is without effect on lysine accessibility but antagonizes ATP inhibition of lysine modifi  cation. Tandem elec-
trospray ionization mass spectrometry analysis indicates that ATP reduces covalent modifi  cation of lysine residues 
245, 255, 256, and 477, whereas labeling at lysine residues 225, 229, and 230 is unchanged. Exogenous, intracel-
lular GLUT1 C-terminal peptide mimics ATP modulation of transport whereas C-terminal peptide-directed IgGs 
inhibit ATP modulation of glucose transport. These fi  ndings suggest that transport regulation involves ATP-
  dependent conformational changes in (or interactions between) the GLUT1 C terminus and the C-terminal half 
of GLUT1 cytoplasmic loop 6–7.
INTRODUCTION
Blood–tissue barriers, which comprise endothelial cells 
connected by tight junctions (Takata et al., 1997; Mann 
et al., 2003), protect the brain, peripheral nerve, myo-
cardium, retina, olfactory epithelium, and the inner ear 
from the external environment. Metabolism in these tis-
sues is fueled by glucose that is transported across the 
endothelial barrier via a transcellular mechanism medi-
ated by the type I facilitative glucose transport protein, 
GLUT1 (Takata et al., 1997; Mann et al., 2003; Leybaert, 
2005). GLUT1 is a prototypic member of the facilitative 
glucose transporter family (Joost et al., 2002) and of the 
wider major facilitator superfamily (MFS) of structur-
ally and functionally related transport proteins (Saier 
et al., 1999; Saier, 2000).
GLUT1 is expressed at very high levels in endothelial 
cells and erythrocytes (Takata et al., 1997) where it dis-
plays substrate affi  nities, kinetic properties, and inhibi-
tor pharmacodynamics that distinguish it from other 
GLUT facilitative sugar transporter members (Takakura 
et al., 1991). Glucose metabolism in erythrocytes and 
endothelial cells is not rate limited by transport because 
the glucose transport capacities of these cells greatly ex-
ceeds their glycolytic capacities (Jacquez, 1984; Gerritsen 
et al., 1988). In spite of this, GLUT1-mediated sugar trans-
port displays acute and adaptive regulation in endothelial 
cells (Takata et al., 1997; Loaiza et al., 2003; Mann et al., 
2003) and acute regulation in erythrocytes (Jung et al., 
1971; Taverna and Langdon, 1973; Jacquez, 1983; Weiser 
et al., 1983; Levine et al., 2005) where cellular ATP de-
pletion enhances GLUT1-mediated sugar import capacity 
(Carruthers and Zottola, 1996; Heard et al., 2000; Levine 
et al., 2002; Levine et al., 2005; Leitch and Carruthers, 
2007). Acute responses occur within seconds to minutes 
and involve stimulation of existing cell surface glucose 
transporters (Diamond and Carruthers, 1993; Shetty 
et al., 1993; Cloherty et al., 1996). Adaptive responses 
occur over several hours in response to hypoxia and hypo-
glycemia and involve changes in glucose transporter ex-
pression (Mann et al., 2003).
GLUT1 is a nucleotide binding protein that, when 
complexed with ATP, displays reduced glucose import 
capacity but increased affi  nity for sugar (Carruthers 
and Helgerson, 1989; Levine et al., 1998; Levine et al., 
2002). ATP modulation of GLUT1-mediated transport 
is competitively inhibited by AMP and ADP, but does 
not require ATP hydrolysis (Heard et al., 2000). Peptide 
mapping studies of azidoATP-labeled GLUT1 demon-
strate that ATP interacts with GLUT1 residues 301–364 
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(Levine et al., 1998). This sequence spans transmem-
brane helices 8 and 9 (TM8 and TM9) and cytoplasmic 
loop 8–9. Residues 332–343 of this region display 50% 
sequence identity with a component of the adenylate 
kinase ATP binding pocket (Levine et al., 1998) and muta-
genesis of key residues within this subdomain abolishes 
ATP modulation of transport (Levine et al., 2002). These 
observations suggest that nucleotide binding pocket 
minimally consists of L8–9 and a portion of TM9. Com-
petitive antagonism of ATP regulation of transport by 
AMP eliminates the possibility that transport regula-
tion is a simple consequence of nucleotide binding to 
GLUT1. Rather, regulation must involve nucleotide-
induced GLUT1 conformational changes but the nature 
of these changes is unknown. Neither is it known whether 
the details of GLUT1 regulation are isoform specifi  c 
or refl  ect a mechanism fundamental to all structurally re-
lated GLUT family members that extends to transport 
catalyzed by other structurally and functionally related 
MFS proteins. GLUT1 regulation appears to involve rapid 
changes in GLUT1 intrinsic activity while regulation of 
the insulin-sensitive transporter GLUT4 involves rapid 
redistributions of GLUT4 proteins between intracellular 
and cell surface membranes in addition to GLUT4 activa-
tion (Joost et al., 1986; Simpson and Cushman, 1986).
The results of the present study suggest that ATP bind-
ing to GLUT1 causes the GLUT1 carboxyl terminus to 
interact with GLUT1 cytoplasmic loop 6–7 in a sequence-
specifi  c fashion to inhibit transport.
MATERIALS AND METHODS
Materials
Fresh, de-identifi  ed human blood was purchased from Biological 
Specialties Corporation. Protein assays, Pro Blue coomassie stain, 
and Supersignal chemiluminescence kits were from Pierce Chemical 
Co. Nitrocellulose and Immobilon-P were purchased from Fisher 
Scientifi  c. Purifi  ed rabbit IgGs raised against synthetic peptides 
corresponding to GLUT1 subdomains were obtained from Animal 
Pharm Services, Inc. These are N-Ab (GLUT1 residues 1–13); 
L2–3-Ab (GLUT1 residues 85–95); L6–7-Ab (GLUT1 residues 217–
231); L7–8-Ab (GLUT1 residues 299–311); C-Ab (GLUT1 residues 
480–492). All other reagents were purchased from Sigma-Aldrich.
Solutions
Saline comprises 150 mM NaCl, 10 mM Tris-HCl, and 0.5 mM 
EDTA, pH 7.4. Lysis medium contained 10 mM Tris-HCl and 
0.2 mM EDTA, pH 7.2. Stripping solution contained 2 mM EDTA, 
15.2 mM NaOH, pH 12. Tris medium contained 50 mM Tris-HCl, 
pH 7.4. Kaline consisted of 150 mM KCl, 5 mM HEPES, 4 mM 
EGTA, and 5 mM MgCl2. Ammonium bicarbonate was 0.5% 
(63 mM), pH 9.0. PBS containing Tween (PBS-T) comprised 140 
mM NaCl, 10 mM Na2HPO4, 3.4 mM KCl, 1.84 mM KH2PO4, 
0.1% Tween, pH 7.3. Stop solution comprises ice-cold Kaline plus 
cytochalasin B (CB) (10 μM) and phloretin (100 μM).
Red Cells and Red Cell Ghosts
Red cells were isolated by as described previously (Leitch and 
Carruthers, 2007). Red cell ghosts were formed by reversible hypo-
tonic lysis of washed red cells (Leitch and Carruthers, 2007).
GLUT1 Puriﬁ  cation
Glucose transporter (plus endogenous lipids) was purifi  ed from 
human erythrocyte membranes in the absence of reductant as de-
scribed previously (Hebert and Carruthers, 1992). The resulting 
GLUT1 proteoliposomes contain (by protein mass) 90% GLUT1, 
8% RhD protein, 2% nucleoside transporter (ENT1) and have a 
lipid:total protein mass ratio of 1:1 (Zottola et al., 1995). Experi-
ments were restricted to the use of GLUT1 preparations in which 
the stoichiometry of proteoliposomal cytochalasin B binding is 
0.48 ± 0.07 mol CB per mol nonreduced GLUT1 and 0.9 ± 0.1 
mol CB per mol reduced GLUT1.
Sugar Transport Determinations
Transport in red cell ghosts was measured as described previously 
(Leitch and Carruthers, 2007).
Limited Proteolytic Digestion of Puriﬁ  ed GLUT1
Purifi  ed GLUT1 (10 μg) was digested with a 20:1 (protein:
enzyme) ratio of purifi  ed porcine trypsin (Princeton Separations) 
in 50 mM Tris-HCl (pH 7.5), 5 mM MgCl2, 4 mM ATP (pH 7.5). 
Digestions were performed at 4°C for 60 min, or the indicated 
time period. Reactions were immediately loaded onto 15% 
SDS-PAGE.
Western Blotting
After SDS-PAGE, samples were transferred to nitrocellulose and 
blocked overnight in 25% nonfat dry milk/PBS-T. Primary anti-
body (N-Ab [1:200], L2–3-Ab [1:200], L6–7-Ab [1:500], L7–8-Ab 
[1:200], L8–9 [1:200], C-Ab [1:15,000], δ-Ab [1:1,000]) was incu-
bated in 3% nonfat dry milk/PBS-T for 1 h at room temperature. 
Blots were washed three times in PBS-T and incubated with horse-
radish peroxidase (HRP)–conjugated goat anti-rabbit secondary 
antibody (1:5,000 dilution) at room temperature for 1 h. Blots 
were washed three times in PBS-T, developed using Pierce Super-
Signal West Pico Chemiluminescent substrate and visualized by 
autoradiography.
ELISA
Purifi  ed GLUT1 (200 ng) in PBS was adsorbed to each well of the 
ELISA plate for 2 h at 37°C. Plates were blocked with PBS + 3% 
BSA for 2 h at 37°C. Primary antibody (N-Ab [1:200], L2–3-Ab 
[1:200], L6–7-Ab [1:500], L7–8-Ab [1:200], L8–9 [1:100 to 1:500], 
C-Ab [1:15,000], δ-Ab [1:1,000]) was added to each well in PBS + 
0.1% BSA ± ATP and binding was allowed to proceed for 2 h. The 
plate was washed fi  ve times with PBS, and then each well was incu-
bated with HRP-conjugated goat anti-rabbit secondary antibody 
in PBS + 0.1% BSA (1:5,000 dilution) for 1 h at 37°C. The plate 
was washed fi  ve times with PBS and wells were developed using 
100 μl of 1-Step ABTS solution (Pierce Chemical Co.). Primary 
IgG binding was quantitated as absorbance at 415 nm.
Construction of the GLUT1–L6-7–GLUT4 Chimera
This chimera substitutes the middle loop (L6–7) with that of its 
rat GLUT4 counterpart and was constructed using a six-step PCR 
protocol. In PCR 1A, a HindIII primer complimentary to the 
5′ end of human GLUT1 and a reverse primer complimentary to 
nucleotides 600–619 of GLUT1 and 667–685 of GLUT4 was used 
to generate a fragment containing TM 1–6 (nucleotides 1–620) 
of GLUT1. In a separate reaction, PCR1B, primer (T  G  C  A  T  C  G  T  G-
C  T  G  C  C  C  T  T  C  T  G  T  C  C  T  G  A  G  A  G  C  C  C  C  C  G  A  ) containing sequence 
complimentary to nucleotides 600–619 of GLUT1 and 667–685 of 
GLUT4 (5′end of L6–7) and a reverse primer (containing a NotI 
restriction site) complimentary to the 3′ end of GLUT4 was used 
to generate a fragment containing the middle loop and TM 7–12 
(nucleotides 667–1531) of GLUT4. In PCR2, the HindIII primer 
complimentary to the 5′ end of human GLUT1 and the reverse 
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3′ end of GLUT4 were used along with the products from PCR1A 
and B to generate an intermediate chimera containing sequence 
from nucleotides 1–620 of GLUT1 and 667–1531 of GLUT4. This 
intermediate chimera contained TM 1–6 of GLUT1 in frame with 
L6–7 and TM 7–12 of GLUT4. In PCR 3A, the HindIII primer 
complimentary to the 5′ end of human GLUT1 and a primer 
(C  G  C  A  C  C  C  A  G  G  G  G  C  A  G  C  C  T  A  T  C  C  T  C  A  T  C  G  C  T  G  T  G  G  T  C  ) com-
plimentary to nucleotides 844–862 of GLUT4 and 815–829 of 
GLUT1 were used along with the product from PCR2 to generate 
a fragment containing TM 1–6 of GLUT1 (nucleotides 1–619) 
in frame with L6–7 (nucleotides 667–862) of GLUT4. In PCR 
3B, a primer (C  G  C  A  C  C  C  A  G  G  G  G  C  A  G  C  C  T  A  T  C  C  T  C  A  T  C  G  C  T  G-
T  G  G  T  C  ) complimentary to nucleotides 844–862 of GLUT4 and 
nucleotides 815–829 of GLUT1 were used with wild-type GLUT1 
plasmid as a template to generate a fragment containing TM 7–12 
(nucleotides 815–1480) of GLUT1. In the fi  nal reaction, PCR 4, 
HindIII primer complimentary to the 5′ end of human GLUT1 
and the NotI primer complimentary to the 3′ end of GLUT1 were 
used with the products of PCR 3A and B as a template generating 
the fi  nal product, which contained TM 1–6 (nucleotides 1–619) 
of GLUT1, followed by L6–7 of GLUT4 (nucleotides 667–862), 
followed by TM 7–12 (nucleotides 815–1480) of GLUT1. This 
PCR product was digested with HindIII and NotI and ligated 
into the mammalian expression vector pcDNA 3.1+, cut with the 
same enzymes. Sequences were confi  rmed by sequencing and the 
chimera was transiently expressed in HEK 293 cells as described 
previously (Levine et al., 2005).
Modiﬁ  cation of GLUT1 Lysine Residues 
by Sulfo-NHS-LC-Biotin
GLUT1 was covalently modifi   ed at accessible lysine residues (±ATP) 
using sulfosuccinimidyl-6-(biotinamido) hexanoate (sulfo-NHS-
LC-biotin) as described previously (unpublished data). Detection 
of modifi  ed residues was achieved by limited proteolysis of 
labeled GLUT1 followed by RP-HPLC separation of fragments 
and ESI-MS/MS identifi  cation of peptides as described previously 
(unpublished data).
RESULTS
Human GLUT1 copurifi  es with red cell membrane lipids 
and is reconstituted into unsealed proteoliposomes upon 
detergent removal (Baldwin et al., 1979; Appleman and 
Lienhard, 1985; Sultzman and Carruthers, 1999). Although 
sealed proteoliposomes may be formed if exogenous 
lipid is added before detergent dialysis (Baldwin et al., 
1982; Carruthers and Melchior, 1984; Zeidel et al., 1992), 
we employed purifi  ed human GLUT1 in unsealed proteo-
liposomes to ensure that added reagent has access to 
both surfaces of the lipid bilayer and thus full access to 
exo- and endofacial GLUT1 domains.
ATP Protects GLUT1 against Tryptic Digestion
Exposure of GLUT1 proteoliposomes to trypsin (62.5:1 by 
mass) at 37°C results in the rapid loss of intact GLUT1 as 
judged by silver stain detection of peptides resolved by 
10% SDS-PAGE. The time course of GLUT1 proteolysis is 
characterized by a rapid burst phase of proteolysis in which 
 30% of GLUT1 is hydrolyzed with a τ of 4.5 s (Fig. 1 A). 
The remaining intact GLUT1 is proteolyzed with a τ of 
2,500 s (see Fig. 1 B). Addition of ATP (0.1 to 4 mM always 
in the presence of 5 mM MgCl2) to the reaction reduces 
the size and rate of the proteolysis burst phase signifi  cantly 
(extent = 22%, τ = 56 s; Fig. 1 B). AMP, ADP, GTP, and 
CTP do not affect the rate or extent of trypsin-catalyzed 
Figure 1.  Kinetics of GLUT1 digestion by trypsin at 37°C. GLUT1 
(10 μg) was incubated with trypsin (0.16 μg) ± 4 mM ATP (plus 
5 mM MgCl2) for 60 s (A and B) or with 0 ATP, 4 mM ATP, or 
4 mM GTP for the times indicated (B). Peptides were separated by 
SDS-PAGE and the fraction of intact GLUT1 remaining quanti-
tated by densitometry of silver-stained gels. The bars to the left of 
the gel in A indicate the mobility of molecular weight standards 
(113, 92, 50.1, 35.4, 29, 21.5 kD from top to bottom). The curves 
drawn through the data points in B assume two exponential 
phases of proteolysis. The fast phase accounts for 33 ± 2% of 
GLUT1 proteolysis and has a fi  rst order rate constant of 0.055 ± 
0.008 per second (control, ●) or 0.049 ± 0.026 per second (GTP, 
△). The slow phase accounts for 66% of GLUT1 digestion and 
has a fi  rst order rate constant of 0.00027 ± 0.00007 per second 
(control, ●) or 0.00026 ± 0.00022 per second (GTP, △). ATP 
(○) reduces the size of the fast phase to 22 ± 2% and slows the 
fast rate constant to 0.017 ± 0.003 per second. Insuffi  cient data 
exists to analyze slow phase kinetics in the presence of ATP. Data 
are shown as mean ± SEM of fi  ve separate experiments. (C) ATP 
protection of GLUT1 during fast phase proteolysis is half-maxi-
mal at 627 ± 268 μM ATP. Data are shown as mean ± SEM of 3 
separate experiments.160 ATP-dependent GLUT1 Conformational Changes
GLUT1 proteolysis. ATP inhibits GLUT1 digestion at 60 s 
by 50% at 627 ± 268 μM ATP (Fig. 1 C).
To evaluate which GLUT1 domains were most suscep-
tible to proteolysis, we examined GLUT1 fragmentation 
patterns by immunoblot analysis of GLUT1 digests 
using a series of GLUT1 peptide-directed IgGs. These 
included N-Ab (directed against GLUT1 amino acids 
1–13), L6–7-Ab (directed against GLUT1 residues 217–
231), L7–8-Ab (GLUT1 residues 299–311), and C-Ab 
(residues 480–492). ATP (4 mM) reduces the effi  ciency 
of GLUT1 digestion (100:1 GLUT1:trypsin by mass, 20°C, 
30 min reaction) as detected by immunoblot using IgGs 
specifi  c to each of these GLUT1 subdomains (Fig. 2 A). 
For example, the C-Ab panel indicates the absence of 
higher molecular weight C-Ab–reactive fragments when 
GLUT1 proteolysis proceeds in the absence of ATP. 
When ATP is included, however, both high and low molec-
ular weight C-Ab–reactive fragments are visible and more 
abundant, suggesting a general slowing of proteolysis 
of both intact and partially cleaved GLUT1. To identify 
protected peptides, we aligned each GLUT1 peptide 
detected by immunoblot analysis to GLUT1 sequence 
using two criteria: (1) the fragment must contain the re-
active epitope, and (2) the mass (electrophoretic mobility) 
of the fragment must be consistent with previously de-
tected GLUT1 tryptic cleavage sites (unpublished data). 
Figure 2.  Immunoblot analysis of 
trypsin-digested, purifi  ed GLUT1 ± 
4 mM ATP. The digest was analyzed 
by Western blot analysis using a panel 
of antibodies directed against specifi  c 
GLUT1 domains: N-Ab (GLUT1 resi-
dues 1–13); L6–7-Ab (GLUT1 resi-
dues 217–231); L7–8-Ab (GLUT1 
residues 299–311); and C-Ab (GLUT1 
residues 480–492). (A) Immunoblot 
analysis of tryptic digests. The key 
indicates the presence (+) or absence 
(−) of trypsin (tryp) or ATP (4 mM). 
The bars to the left of each blot 
show the mobility of molecular weight 
standards (kD). The arrows to the 
right of each blot indicate peptides 
whose intensity is greater when di-
gests are performed in the presence 
of ATP. (B) Linear representation of 
GLUT1. The open boxes show the 
locations of N-Ab, L6–7-Ab, L7–8-Ab, 
and C-Ab directed IgG binding do-
mains. The vertical arrows indicate 
GLUT1 tryptic cleavage sites deter-
mined by MS/MS analysis of GLUT1 
tryptic digests. The horizontal bars 
below indicate putative assignments 
of ATP-sensitive GLUT1 peptides 
detected by peptide-directed IgGs 
and their theoretical molecular 
weight (kD). (C) [ATP] dose response 
to trypsin digestion. The relative inten-
sities of C-Ab–reactive 20 kD (●) and 
25–27 kD (○) peptides increase with 
[ATP] during proteolysis. Peptide in-
tensity (volume) was quantitated by 
densitometry of immunoblots using 
the Image J software package and 
plotted as a function of [ATP]. Curves 
were computed by nonlinear regres-
sion assuming that intensity increases 
with [ATP] in a simple, saturable 
fashion. 20 kD and 25–27 kD pep-
tides are half maximally protected 
by ATP at (366 ± 202) and (440 ± 
211) μM, respectively. This fi  gure 
represents a single dose–response 
experiment.  Blodgett et al. 161
The trypsin-accessible sites observed here are generally 
consistent with the surface accessibility maps produced 
by systematic cysteine scanning mutagenesis of GLUT1 
(Mueckler and Makepeace, 2006).
Fig. 2 B summarizes potential alignments of protected 
peptides. GLUT1 is most susceptible to tryptic diges-
tion at cytoplasmic loop 6–7 and at the C terminus. 
ATP protection is distributed across GLUT1 primary 
structure. ATP inhibition of trypsin-catalyzed GLUT1 
proteolysis increases in a saturable manner with ATP con-
centration and is half maximal at  400 μM ATP (n = 1; 
Fig. 2 C).
ATP-dependent GLUT1 Conformational Changes
The results of the proteolysis experiments suggest that ATP 
promotes signifi  cant GLUT1 conformational changes. 
To determine whether this also occurs in intact GLUT1, 
we analyzed ATP-dependent changes in GLUT1 epitope 
accessibility by measuring peptide-directed IgG bind-
ing to membrane-resident GLUT1. GLUT1 proteolipo-
somes were adsorbed to ELISA wells and then incubated ± 
ATP and peptide-directed IgGs. As reported previ-
ously (Carruthers and Helgerson, 1989), ATP inhibits 
C-Ab binding to GLUT1 proteoliposomes (Fig. 3 A; 
Table I). This is also observed with C-Ab binding to un-
sealed red cell membranes (Fig. 3 B) and in membranes 
isolated from HEK cells heterologously expressing wild-
type human GLUT1 (Fig. 3 C). When HEK293 cells are 
transfected with a GLUT1–GLUT4 chimera in which 
the GLUT1 large middle loop (L6–7) is replaced by 
equivalent GLUT4 sequence, ATP inhibition of C-Ab 
binding to the GLUT1 C terminus of the chimera is lost 
Figure 3.  Time course of C-Ab binding to ELISA dish–
immobilized GLUT1 proteoliposomes (A), red cell 
membranes (B), HEK cell membranes expressing GLUT 
(C), and HEK cell membranes expressing the GLUT1–
GLUT4 loop 6 chimera in which GLUT1 L6–7 is substi-
tuted by GLUT4 L6–7 (D). Ordinate, extent of C-Ab 
binding (OD415); Abscissa, duration of C-Ab exposure to 
membranes (min). Filled circles (●) show C-Ab binding 
in the presence of ATP (4 mM), and open circles (○) 
show C-Ab binding in the absence of ATP. Results are the 
mean ± SEM of quadruplicate measurements. Each ex-
periment was repeated three or more times (A–C) or 
twice (D). Open triangles show C-Ab binding to mem-
branes isolated from untransfected HEK cells. Curves 
were calculated assuming a single exponential phase of 
IgG binding described by B (1 − e−kt), where B is equi-
librium binding, k is the fi  rst order rate constant for 
binding, and t is time. The results are summarized in 
Table I. The inset of D shows a C-Ab immunoblot of HEK 
membranes (20 μg) isolated from untransfected cells 
(lane 1), cells transfected with wt GLUT1 (lane 3), and 
cells transfected with the GLUT1–GLUT4 loop 6 chi-
mera (lane 2). The bars to the left of the blot indicate 
the mobility (top to bottom) of 108-, 90-, and 51-kD 
molecular weight standards.
TABLE I
Effects of ATP on C-Ab Binding to GLUT1
Equilibrium binding k per min
[ATP] mM [ATP] mM
Membranes 0 4 P 0 4
GLUT1 0.65 ± 0.012 0.46 ± 0.02 <0.001 0.13 ± 0.06 0.12 ± 0.01
RBC 0.84 ± 0.13 0.49 ± 0.05 <0.001 0.10 ± 0.03 0.17 ± 0.05
wtGLUT1 0.67 ± 0.02 0.47 ± 0.03 <0.001 0.11 ± 0.01 0.11 ± 0.01
GLUT1–GLUT4 (L6) chimera 0.63 ± 0.02 0.56 ± 0.04 >0.10 0.14 ± 0.05 0.12 ± 0.01
Results from the curve fi  ts of Fig. 3. C-Ab binding to GLUT1 is a simple exponential process characterized by a constant, B, that describes the extent of 
binding at equilibrium and by a rate constant k (per min). Binding was measured in the absence and presence of 4 mM ATP. Binding to GLUT1 was 
measured in GLUT1 proteoliposomes (GLUT1), in red cell membranes (RBC), in membranes isolated from HEK cells expressing wild-type GLUT1 
(wtGLUT1), and in membranes isolated from HEK cells expressing the GLUT1–GLUT4 loop 6 chimera (GLUT1–GLUT4 (L6) chimera). P is a test of 
the hypothesis that binding in the absence of ATP is identical to binding in the presence of 4 mM ATP (t test of equilibrium binding obtained in three 
or more experiments). k is unaffected by ATP.162 ATP-dependent GLUT1 Conformational Changes
(Fig. 3 D; Table I). Analysis of equilibrium C-Ab  binding 
to these membranes indicates that ATP signifi  cantly 
reduces C-Ab binding to purifi  ed GLUT1, red cell–
  resident GLUT1 and wtGLUT1 (P < 0.001) but not 
to the GLUT1–GLUT4 loop 6 chimera (P > 0.1). This 
chimera is expressed effi  ciently (Fig. 3 D) and reaches 
the cell surface where it facilitates 2-deoxy-d-glucose 
transport. Untransfected HEK cells are characterized by 
Vmax and Km(app) for 2-deoxy-d-glucose uptake at 30°C of 
1.2 ± 0.1 pmol/μg cell protein/min and 3.6 ± 1.4 mM, 
respectively. HEK cells transfected with wild-type GLUT1 
(1.6 μg DNA per 106 cells) show signifi  cantly greater 
2-deoxy-d-glucose uptake and are characterized by Vmax 
and Km(app) of 29.3 ± 9.4 pmol/μg cell protein/min 
and 3.6 ± 1.4 mM, respectively. Cells transfected with 
the loop 6–7 GLUT1–GLUT4 chimera (1.6 μg DNA per 
106 cells) are characterized by Vmax and Km(app) for 
2-deoxy-d-glucose uptake of 21.6 ± 2.6 μmol/106 cells/min 
and 1.7 ± 0.7 mM, respectively.
To understand whether this response is restricted to 
the GLUT1 C terminus or more widespread, we exam-
ined the available peptide-directed IgGs for ability to 
bind to intact GLUT1 and for sensitivity of binding to 
ATP (Table II). ATP does not affect binding of ∂-Ab, 
loop 2–3-Ab or loop 6–7-Ab to membrane-resident 
GLUT1 but does reduce loop 7–8-Ab and C-Ab binding 
to GLUT1 proteoliposomes. N-Ab and loop 8–9-Ab 
binding to native GLUT1 structure are undetectable, 
indicating that these epitopes are inaccessible in mem-
brane-resident GLUT1.
ATP-dependent Changes in Amino Acid 
Side Chain Accessibility
We assessed whether ATP-dependent conformational 
changes in loop 6–7 and the C terminus are refl  ected at 
the level of specifi  c amino acid side chains by analysis of 
ATP modulation of sulfo-NHS-LC-biotin covalent modi-
fi  cation of loop 6–7 and C terminus lysine residues. 
GLUT1 proteoliposomes were preincubated in the pres-
ence or absence of 4 mM ATP before addition of a 
20-fold molar excess of sulfo-NHS-LC-biotin to initiate 
GLUT1 labeling. This ratio of probe to GLUT1 pro-
duces signifi  cant labeling of GLUT1 cytoplasmic loop 
lysine residues without affecting the ability of GLUT1 to 
bind cytochalasin B (unpublished data). ATP reduces 
the extent of GLUT1 modifi  cation by  40%, without 
slowing the reaction rate (Fig. 4 A). ATP inhibition 
of labeling is half maximal at 2 mM ATP (Fig. 4 B). AMP 
(0 to 4 mM) alters neither the rate nor the extent of 
GLUT1 modifi  cation but increases the amount of ATP 
required to inhibit GLUT1 modifi  cation. When the 
concentration dependence of ATP inhibition of GLUT1 
modifi  cation is measured in the presence of 2 mM AMP, 
the effects of ATP are half maximal at 3.8 mM. Assuming 
AMP competitively antagonizes ATP inhibition of modi-
fi  cation, Ki(app) for AMP antagonism of ATP modulation 
of GLUT1 is 2.2 mM (Fig. 4 B).
GLUT1 lysine residues whose accessibility to sulfo-
NHS-LC-biotin is specifi  cally affected by ATP were iden-
tifi  ed by ESI-MS/MS analysis of labeled GLUT1. After 
GLUT1 biotinylation in the presence of 4 mM AMP 
(control) or ATP and subsequent tryptic digestion/ESI-
MS-MS, we identifi  ed all peptides originating from 
a specifi  c GLUT1 region and quantitated each peak 
area. The peak areas of biotinylated peptides in a 
denoted region were summed and expressed as the 
fraction of all peptides (labeled and unlabeled) in that 
region. Fig. 5 shows a representative analysis of lysine 
245 modifi  cation.
To simplify the analysis, cytoplasmic GLUT1 lysine 
residues were grouped into four regions based on se-
quence location (see Fig. 6): region 1 contains K225, 
K229, and K230; region 2 contains K245; region 3 com-
prises K255 and K256; region 4 contains K477. Regions 
1, 2, and 3 are located in cytoplasmic loop-6–7. Region 4 
lies in the GLUT1-C terminus.
TABLE II
Effects of ATP on Peptide-directed IgG Binding to GLUT1
GLUT1 IgG and domain IgG binding by Western blot IgG binding to proteoliposomes Effect of ATP on IgG binding to proteoliposomes
N-Ab; 1–13 Yes (1:200) ND NA
L2–3-Ab; 84–96 Yes (1:200) Yes No effect
L6–7-Ab; 217–231 Yes (1:500) Yes No effect
L7–8-Ab; 299–311 Yes (1:200) Yes Inhibits
L8–9-Ab; 329–241 Yes (1:200) ND NA
C-Ab; 480–492 Yes (1:15,000) Yes Inhibits
Exofacial (δ-Ab) Yes (1:1,000) Yes No effect
Immune sera generated against synthetic peptides corresponding to the indicated GLUT1 amino acid residues were raised in rabbits (e.g., N-Ab is immune 
serum raised against GLUT1 amino acids 1–13). IgG binding was measured by immunoblot analysis of proteins resolved by SDS-PAGE (see Fig. 1) or 
by ELISA analysis of binding to GLUT1 proteoliposomes (see Fig. 2). The serum dilution used in immunoblot analyses is indicated in parenthesis. Yes 
indicates specifi  c binding is detectable. ND indicates that binding is not detectable. The effect of 4 mM ATP on IgG binding was measured. Inhibits indicates 
that equilibrium binding is reduced by >25% (see Fig. 2). NA indicates that the experiment is not applicable because IgG binding to proteoliposomes 
is undetectable. Exofacial GLUT1 domain-reactive polyclonal IgGs (δ-Ab) were raised against nonreduced, native GLUT1. The reactive epitope is 
not known.  Blodgett et al. 163
Region 1 shows no discernible change in the quantity 
of labeled peptide in the presence of ATP (Fig. 6). 
  Regions 2, 3, and 4 show decreased lysine modifi  cation 
in the presence of ATP (Fig. 6). ATP reduces labeling of 
K245 of region 2 by 38% (see Fig. 5 A [AMP] and Fig. 
5 B [ATP]). Similarly, region 3 displays a 24% reduction 
and labeling of K477 of region 4 shows a 26% decrease 
in the presence of ATP (Fig. 6). Overall, ATP reduces 
labeling of lysine residues found within the C-terminal 
half of L6–7 and the C terminus of GLUT1 by  30%.
Effects of the GLUT1 C Terminus on Sugar Transport
These fi  ndings reinforce the hypothesis that the GLUT1 
C terminus and loop 6–7 undergo signifi  cant conforma-
tional change in the presence of cytoplasmic ATP. We 
asked, therefore, how complexation of the C terminus 
using intracellular C-Ab might impact ATP modulation 
of sugar transport. ATP increases the rate of sugar trans-
port at subsaturating 3MG because at these sugar con-
centrations the rate of transport, v, is given by:
  =
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where [S] is the sugar concentration. ATP reduces Vmax 
and Km(app) for net 3MG uptake by red cell ghosts at 4°C 
by 8- and 18-fold, respectively (Helgerson et al., 1989), 
thereby increasing the ratio Vmax/ Km(app) and the rate of 
subsaturating transport by 2.3-fold (Table III).
Incorporation of GLUT1 C-Ab into resealed erythro-
cyte ghosts severely blunts ATP stimulation of 3MG up-
take at 4°C (Table III). Preimmune serum and loop 
6–7-Ab are without effect on ATP action.
Exogenous, intracellular GLUT1 C-terminal peptide 
(E  E  L  F  H  P  L  G  A  D  S  Q  V  ), but not 1D4 peptide (ETQSVAPA, 
a rhodopsin peptide), mimics the ability of ATP to stim-
ulate sugar transport and acts synergistically with ATP 
(Table III). In the absence of ATP, C-terminal peptide 
triples the rate of 3MG uptake and is half maximally 
active at 9 μM.
DISCUSSION
This study examines the structural basis of GLUT1 
modulation by cytoplasmic ATP and AMP. Our fi  ndings 
suggest that the GLUT1 cytoplasmic C terminus and the 
cytoplasmic loop linking TMs 6 and 7 interact in an ATP-
dependent fashion to modulate transport.
ATP-dependent GLUT1 Functional Changes
Human GLUT1 responds acutely to cellular ATP  depletion 
with enhanced sugar transport capacity (Jung et al., 1971; 
Figure 4.  Analysis of ATP modulation of lysine modification. 
(A) Time course of GLUT1 labeling by sulfo-NHS-LC-biotin. GLUT1 
proteoliposomes were preincubated in buffer lacking (○) or con-
taining 4 mM AMP (●) or 4 mM ATP (■) before addition of 
sulfo-NHS-LC-biotin. Ordinate, extent of labeling (measured as 
OD415); abscissa, time in minutes. Results are shown as mean ± 
SEM of at least four determinations. Biotinylation kinetics follow 
pseudo-fi  rst order kinetics where labeling equals B0 + B∞(1 − e−kt). 
The curves have the following constants: buffer (○), B0 = 0.15 ± 
0.02, B∞ = 1.09 ± 0.05, k = 0.0023 ± 0.003 per minute; AMP (●), 
B0 = 0.16 ± 0.01, B∞ = 1.20 ± 0.03, k = 0.0019 ± 0.0001 per min-
ute; ATP (■), B0 = 0.098 ± 0.009, B∞ = 0.66 ± 0.02, k = 0.0022 ± 
0.0002 per minute. (A, inset) Average B∞ (±SEM) of at least 
three labeling experiments made in triplicate for control, 4 mM 
AMP, and 4 mM ATP conditions. (B) Effects of nucleotides on 
equilibrium GLUT1 biotinylation. Ordinate, extent of total biotin 
incorporation (shown as mean ± SEM; n = 3 or greater); abscissa, 
[AMP] or [ATP] (mM) present during labeling. The pseudo-fi  rst-
order rate constant describing GLUT1 labeling by sulfo-NHS-LC-
biotin is unaffected by nucleotides. The extent of labeling is not 
signifi  cantly affected by AMP alone (●). Assuming labeling is de-
scribed by BC − BN[nucleotide]/(Ki + [nucleotide]), nonlinear 
regression analysis indicates that for labeling in the presence of 
ATP (■), BC = 1.210 ± 0.007, BN = 0.72 ± 0.04, and Ki = 2.1 ± 
0.1 mM. ATP inhibition of labeling was also measured in the  presence 
of 2 mM AMP (△), where BC = 0.9, BN = 0.6, and Ki = 3.8 ± 1.5 mM. 
AMP therefore anatagonizes ATP modulation of biotinylation 
with Ki(app) for AMP = 2.2 mM.164 ATP-dependent GLUT1 Conformational Changes
Taverna and Langdon, 1973; Weiser et al., 1983; Cloherty 
et al., 1996; Levine et al., 2002). This effect is direct 
(Hebert and Carruthers, 1986; Carruthers and Helgerson, 
1989), does not require ATP hydrolysis, and is antago-
nized by intracellular H+, AMP, and ADP (Carruthers 
and Helgerson, 1989; Helgerson et al., 1989). GLUT1 
residues 301–364 (TM8 through TM 9) form at least 
one element of the nucleotide binding domain (Levine 
et al., 1998) and site-directed mutagenesis of loop 8–9 
residues (E329A or R332A/R333A) produces an ATP-
insensitive, dominant-negative transporter in HEK cells 
(Levine et al., 2002). The molecular mechanism of 
GLUT1 modulation by ATP is unknown but may involve 
GLUT1 C terminus conformational change (Carruthers 
and Helgerson, 1989).
GLUT1 Structural Changes
Our results demonstrate that ATP–GLUT1 interactions 
promote global changes in GLUT1 conformation. ATP-
dependent GLUT1 protection against trypsin digestion, 
ATP inhibition of IgG binding to GLUT1 subdomains, 
and ATP protection of specifi  c cytoplasmic lysine resi-
dues against modifi  cation by NHS-biotin confi  rm that 
the ATP–GLUT1 complex is conformationally distinct 
from its ATP-free counterpart. ATP inhibits IgG binding 
to the C terminus and to exofacial loop 7–8 of membrane-
resident transporter. ATP does not affect the extent of 
covalent modifi  cation of loop 6–7 lysine residues 225, 
229, and 230 or binding of an antibody directed against 
residues 217–231, indicating that exposure of this fl  exi-
ble loop subdomain to cytoplasmic water is unchanged 
by ATP. This ATP-insensitive region contains a putative 
ATP binding motif (KSVLK; residues 225–229) that is 
also present in GLUT4 loop 6–7 (KSLK), lending fur-
ther support to the hypothesis that this domain is not 
involved in ATP regulation of GLUT1. Labeling of 
loop 6–7 lysine residues 245, 255, and 256 is inhibited 
by ATP, and substitution of GLUT1 loop 6–7 with the 
Figure 5.  K245 accessibility to biotin labeling is modifi  ed by ATP. 
GLUT1 was labeled to equilibrium by sulfo-NHS-LC-biotin in the 
presence of 4 mM AMP (A) or ATP (B), trypsin-digested, and sol-
uble peptides examined by RP-HPLC-ESI-MS/MS. Two peptides 
containing K245 were isolated. The fi  rst (m/z = 1444.7 D; sequence 
R(232).G  T  A  D  V  T  H  D  L  Q  E  M  K  (245).E) was unlabeled and cleaved 
at K245. The second (m/z = 2285.1 D; R(232).G  T  A  D  V  T  H  D  L  Q  E-
M  K  E  E  S  R  (249).Q) was labeled at K245 (339.2 D adduct covalently 
attached to K245) and cleaved at R249. Peak areas were calcu-
lated for each peptide. (A) Labeling conducted in the presence 
of 4 mM AMP. Unlabeled peptide area (●) = 5.54 × 108; labeled 
peptide area (□) = 1.15 × 108; % modifi  ed peptide = 17.24%. 
(B) Labeling conducted in the presence of 4 mM ATP. Unlabeled 
peptide area (●) = 5.09 × 108, labeled peptide area (□) = 5.73 × 
107, % modifi  ed peptide = 10.12%. Labeling of K245 is reduced 
by 41% in the presence of ATP. This is one of three representative 
experiments. Fig. 6 summarizes the extent of ATP inhibition of 
labeling of this and three additional peptides.
Figure 6.  ATP protection of GLUT1 lysine residues. GLUT1 pu-
tative membrane-spanning topography (Salas-Burgos et al., 2004) 
is illustrated. Lysine residues modifi  ed by sulfo-NHS-LC-biotin 
(○) are indicated. This is representative of three separate experi-
ments. Rectangles indicate cytoplasmic regions 1 (K225, K229, 
and K 230), 2 (K245), 3 (K255 and K 256), and 4 (K477). The 
extent (%) of ATP protection against lysine modifi  cation is indi-
cated as a percentage (mean ± SEM of three separate experiments) 
adjacent to each region.  Blodgett et al. 165
equivalent GLUT4 domain greatly diminishes ATP inhi-
bition of IgG binding to the chimera’s GLUT1 C terminus. 
These observations suggest that GLUT1 requires sequence 
present in GLUT1 loop 6–7 in order to occlude the 
C terminus from exogenous IgG. Two of the three ATP-
sensitive lysine residues of loop 6–7 are retained in GLUT4 
loop 6–7 primary structure. This suggests that loop 6–7 
ATP-protected lysine residues do not play a direct role 
in ATP regulation of transport (e.g., ATP binding or salt 
bridge formation with C-terminal residues). Rather, these 
residues may refl  ect altered conformational accessibil-
ity of loop 6–7.
AMP is without effect on GLUT1 loop 6–7 NHS-bio-
tinylation but antagonizes ATP inhibition of labeling. 
AMP also antagonizes ATP inhibition of C-Ab binding to 
GLUT1 (Carruthers and Helgerson, 1989). This behavior 
confi  rms that the functional antagonism between ATP 
and AMP is replicated at the molecular level and that 
ATP modulation of GLUT1 conformation results in 
modulated transport function.
How Do ATP-dependent Structural Changes 
Inﬂ  uence Sugar Transport?
We propose that GLUT1–ATP association promotes con-
formational change within the cytoplasmic GLUT1 C ter-
minus and loop 6–7, resulting in their interaction and 
alignment with sugar translocation pathway (Fig. 7). This 
alignment/interaction limits sugar release into cytoplasm 
and is supported by several observations. (a) Sequestra-
tion of the GLUT1 C terminus by exogenous intracellular 
C-terminal IgGs blunts ATP modulation of sugar trans-
port. (b) Exogenous, intracellular C-terminal peptide 
mimics ATP action of sugar transport. (c) Substitution of 
GLUT1 loop 6–7 with GLUT4 loop 6–7 (40% sequence 
identity with GLUT1 over residues 249–259) prevents ATP 
inhibition of IgG binding to the C terminus.
The action of ATP is thus extrinsic to the membrane-
spanning translocation pathway and intrinsic to cyto-
plasmic domains. This hypothesis is further supported 
by rapid quench fl  ow studies of erythrocyte glucose 
transport, demonstrating that rapid translocation of sugar 
through the sugar translocation pathway is unaffected 
by ATP, but sugar release from the pathway into cytosol is 
regulated by ATP (Blodgett and Carruthers, 2005; Leitch 
and Carruthers, 2007). Loop 6–7 and the C terminus 
may be necessary but not suffi  cient for GLUT1 regulation 
because GLUT1 loop 8–9 mutagenesis causes the loss 
of GLUT1 ATP sensitivity but retention of GLUT1 ATP 
binding (Levine et al., 2002).
Do Other Transporters Use a Similar 
Regulatory Mechanism?
The parallels between channel inactivation and inhibi-
tion of GLUT1 via cytosolic “inactivation domains” are 
striking. Inactivation of multisubunit, voltage-  dependent 
K+ channels and large-conductance, Ca2+-activated K+ 
channels involves insertion of a cytosolic N-terminal 
peptide segment into the ion permeation pathway, thereby 
obstructing ion fl  ux (Kobertz et al., 2000).
Less is known about the intrinsic regulation of other 
members of the GLUT family of proteins or whether 
the broader family of MFS proteins coopt a similar regu-
latory mechanism. MFS proteins contain loop 6–7 do-
mains ranging from 30 to 65 amino acids (Weinglass 
and Kaback, 2000). The LacY and GlpT structures indi-
cate that loop 6–7 and the C terminus cytoplasmic do-
mains do not impede access to the substrate export site 
(Abramson et al., 2003; Huang et al., 2003). However, 
loop 6–7 and the C termini of these structures are con-
siderably shorter than equivalent domains in the mam-
malian sugar porters. Progressive truncation of GLUT1 
loop 6–7 results in loss of transport function followed by 
loss of GLUT1 expression (Monden et al., 2001). The 
former result may refl  ect the loss of residues crucial 
to transport. The latter may refl  ect impaired cotrans-
lational insertion/folding (Weinglass and Kaback, 2000).
The available evidence suggests that the GLUT1 and 
GLUT4 C termini are essential for transport but contain 
isoform-specifi  c subsequence that suppresses intrinsic 
GLUT activity. Truncation of the GLUT1 C terminus by 
12 amino acids is without effect on GLUT1 activity (Lin 
et al., 1992), whereas removal of 37 residues abolishes 
GLUT1 intrinsic activity (Oka et al., 1990). Substitu-
tion of the GLUT1 C-terminal tail with the equivalent 
GLUT4 sequence stimulates GLUT1 intrinsic activity 
twofold but abolishes accelerated exchange transport 
TABLE III
Effects of Intracellular C-terminal Peptide and Cytoplasmic Loop-directed 
IgGs on Red Cell Sugar Transport
Experiment Vmax/Km
No addition 0.26 ± 0.02
ATP 0.53 ± 0.03
13 μM Ctp 0.62 ± 0.05
13 μM Ctp + ATP 1.04 ± 0.07
25 μM 1D4 0.30 ± 0.09
25 μM 1D4 + ATP 0.64 ± 0.11
Preimmune serum 0.23 ± 0.03
Preimmune serum + ATP 0.60 ± 0.08
C-Ab 0.25 ± 0.04
C-Ab + ATP 0.38 ± 0.06
L6–7-Ab 0.20 ± 0.02
L6–7-Ab + ATP 0.55 ± 0.02
Experiments were made using resealed human erythrocyte ghosts containing 
or lacking 4 mM ATP and various other additions which include GLUT1-C-
terminal peptide (Ctp-GLUT1 residues 480–492 at 13 μM); 1D4 (rhodopsin 
peptide ETQSVAPA at 25 μM); preimmune rabbit serum (4 mg/ml); C-Ab 
(20 μg/ml affi  nity purifi  ed IgG raised against GLUT1 Ctp) or L6 rabbit 
serum (immune serum obtained from rabbits immunized with GLUT1 
peptide 217-231; 4 mg/ml). 3MG transport was measured at 4°C at 100 μM 
3MG. The rate constant (per min) is equivalent to Vmax/Km. Results are 
shown as the mean ± SEM of two or four separate measurements made in 
duplicate or triplicate.166 ATP-dependent GLUT1 Conformational Changes
(Dauterive et al., 1996). The C-terminal 20 residues of 
GLUT4 suppress GLUT4 intrinsic activity and deletion 
or replacement of this region with equivalent GLUT1 
sequence increases GLUT4 activity fourfold (Dauterive 
et al., 1996). C-terminal truncation of the organic anion 
transporter OAT1 reduces OAT1 intrinsic activity (Xu 
et al., 2006). These observations support the hypothesis 
that the C-terminal domains of the GLUT sugar por-
ter and the organo anion porter MFS subfamilies are 
essential for transport function and that GLUT1 and 
GLUT4 C termini contain isoform-specifi  c subsequence 
that suppresses intrinsic GLUT activity. Insulin unmasks 
the GLUT4 C terminus in L6 muscle cells (Ishiki et al., 
2005), adipocytes (Smith et al., 1991), and muscle (Wang 
et al., 1996) and desuppresses GLUT4 intrinsic activ-
ity (Michelle Furtado et al., 2003). The present study 
demonstrates that ATP depletion unmasks the GLUT1 
C terminus, resulting in desuppression of GLUT1 intrin-
sic activity.
Relevance to GLUT1 Physiology
Sugar transport in astrocytes, vascular smooth muscle cells, 
basal cardiomyocytes, and cells of the reticuloendothe-
lial system is mediated by GLUT1 (Hruz and Mueckler, 
2001; Mann et al., 2003; Simpson et al., 2007). This 
may result in ATP-sensitive glucose transport in these 
tissues whereby cellular sugar transport capacity is in-
creased in response to ATP depletion. What advantage 
is obtained by GLUT1 regulation in erythrocytes and 
endothelial cells where transport exceeds metabolic de-
mand? The benefit may not be realized by the trans-
porting cell but rather by the cells to which glucose is 
subsequently transferred.
Glucose transfer from blood to brain proceeds across 
capillary endothelial cells that form the blood–brain 
barrier (Takata et al., 1990). Endothelial cells constitute 
only 0.1% of brain mass yet almost all glucose used by 
cerebral neurons and astrocytes enters the brain by 
GLUT1-mediated, transendothelial cell transport (Harik, 
1992). Cerebral endothelial cell GLUT1 content is adap-
tively up-regulated during long-term hypoglycemia and 
hypoxia to meet increased astrocytic and neuronal de-
mand for glycolytic ATP (Mann et al., 2003). Blood–brain 
barrier glucose transport is acutely stimulated during 
seizure-induced stimulation of neuronal and astrocytic 
glycolysis (Cornford et al., 2000). Regulation of barrier 
GLUT1 is, therefore, an important physiologic adapta-
tion and defi  cits in GLUT1 expression or hypoglycemia 
inevitably impact human cognitive function and devel-
opment as observed in GLUT1-defi  ciency syndrome 
(Pascual et al., 2004) and hypoglycemia (Guettier and 
Gorden, 2006).
The very high GLUT1 content of higher primate and 
odontocete erythrocytes may contribute to glucose trans-
fer from blood to tissue (Craik et al., 1998) by allowing 
human red cells to exchange upwards of 82–98% of in-
tracellular glucose with serum in the 2–4 s required for 
an erythrocyte to transit the capillary bed of peripheral 
tissues (Honig et al., 1977; Regittnig et al., 2003). Regu-
lation of erythrocyte glucose transport therefore may 
permit controlled expansion/contraction of the blood 
glucose space available for exchange with the intersti-
tium of glycolytically active tissues.
Conclusions
GLUT1–ATP interaction restructures GLUT1 cytoplas-
mic loop 6–7 and C-terminal domains, resulting in their 
interaction and selective inhibition of sugar release 
from the transmembrane sugar translocation pathway 
into cytosol. This enables GLUT1 to respond to cyto-
plasmic energy charge with low or high capacity glucose 
transport. Interactions between cytoplasmic domains 
may be important in the regulation of other mamma-
lian MFS transport proteins.
Figure 7.  Model for ATP reg-
ulation of GLUT1. GLUT1 
putative membrane-spanning 
topography (Salas-Burgos et al., 
2004) is illustrated. The left-
most topography summarizes 
fi  ndings in the presence of 
AMP. Trypsin cleavage sites 
(K, ○; R, gray circle), sites of 
antibody recognition (gray 
rectangles), and sites where 
IgG binding is not detected 
(white rectangles) are indi-
cated. In the presence of ATP 
(rightmost topography), ATP-
sensitive (crosshatched rect-
angles) and insensitive (gray 
rectangles) IgG binding domains are indicated. The circles show ATP-insensitive tryptic cleavage sites (○), ATP-protected tryptic cleavage 
sites (gray circle), and ATP-protected sites of covalent modifi  cation by sulfo-NHS-LC-biotin (●). We propose that the GLUT1 C terminus 
and the C-terminal half of L6–7 respond to ATP binding by undergoing a conformational change that reduces their respective accessibility 
to polar reagents. This interaction restricts glucose release from the translocation pathway.  Blodgett et al. 167
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